Lupin Company Description

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally.

The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs).

The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies.

In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies.

Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business.

It operates through network consists of labs and collection centers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001.

Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited

Country	India
Founded	1968
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	24,006
CEO	Vinita Gupta

Contact Details

Address: Kalpataru Inspire Mumbai, Maharashtra 400055 India
Phone	91 22 6640 2323
Website	lupin.com

Stock Details

Ticker Symbol	LUPIN
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE326A01037
SIC Code	2834

Key Executives

Name	Position
Vinita D. Gupta	Chief Executive Officer and Executive Director
Nilesh Deshbandhu Gupta	MD and Executive Director
Christoph Funke	Chief Technical Operations Officer